Skip to main navigation Skip to search Skip to main content

Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway

  • Loukik Arora
  • , Chakrabhavi Dhananjaya Mohan
  • , Min Hee Yang
  • , Shobith Rangappa
  • , Amudha Deivasigamani
  • , Alan Prem Kumar
  • , Ajaikumar B. Kunnumakkara
  • , Manoj Garg
  • , Arunachalam Chinnathambi
  • , Sulaiman Ali Alharbi
  • , Tahani Awad Alahmadi
  • , Kanchugarakoppal S. Rangappa
  • , Kam Man Hui
  • , Gautam Sethi
  • , Kwang Seok Ahn

Research output: Contribution to journal › Article › peer-review

30 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science